Clinical Significance of the Costimulatory Molecule B7-H1 in Barrett Carcinoma
- 30 April 2011
- journal article
- research article
- Published by Elsevier BV in The Annals of Thoracic Surgery
- Vol. 91 (4), 1025-1031
- https://doi.org/10.1016/j.athoracsur.2010.12.041
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinomaBMC Cancer, 2010
- Interaction of B7‐H1 on intrahepatic cholangiocarcinoma cells with PD‐1 on tumor‐infiltrating T cells as a mechanism of immune evasionJournal of Surgical Oncology, 2009
- Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancerCancer Letters, 2008
- The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic FactorsNeoplasia, 2006
- Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosisOncogene, 2005
- Cytokines in pancreatic carcinomaCancer, 2004
- The B7–CD28 superfamilyNature Reviews Immunology, 2002
- Identification of human cancers deficient in antigen processing.The Journal of Experimental Medicine, 1993
- Martingale-based residuals for survival modelsBiometrika, 1990
- Martingale-Based Residuals for Survival ModelsBiometrika, 1990